CEPH Message Board - Msg: 122342

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Tran who wrote (12)	6/10/1996 3:02:00 PM
From: Malladi Prasad	of 998

THe latest FDA approval of Myotrophin is good news for Cephalon and Chiron and also all other Bio-tech companies which have drugs pending for approval before the FDA. Ever since Myotrophin's first hearing around JUne last year, the issue of Myotrophin's clearance by the FDA is seen by the entire bio-tech industry as a litmus test of FDA's willingness to bring (speed-up) to market sevearl biotech drugs with potential cure for sevearl life threatening and trminally ill diseases like Lou Gehrig disease (that Myotrophin is meant for). I think the biotech stocks will now come out their spring doldrums and edge up! And we should see some smart money come out of hightech and Banking sectors in to biotechs again! j

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next